questionsmedicales.fr
Phénomènes chimiques
Phénomènes biochimiques
Conformation moléculaire
Conformation des protéines
Éléments structuraux des protéines
Motifs et domaines d'intéraction protéique
Motifs et domaines d'intéraction protéique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Protéines
Bioinformatique
Immunoprécipitation
Interactions protéiques
Bioinformatique
Modélisation moléculaire
Conformation protéique
Complexes protéiques
Mutations
Interactions protéiques
Symptômes
5
Dysfonction protéique
Maladies auto-immunes
Cancer
Maladie d'Alzheimer
Maladies génétiques
Fonctions cellulaires
Inflammation
Troubles neurologiques
Prévention
5
Prévention
Mode de vie sain
Dépistage
Maladies génétiques
Vaccins
Réponse immunitaire
Traitements
5
Médicaments
Anticorps monoclonaux
Thérapie génique
Mutations
Inhibiteurs de protéines
Options thérapeutiques
Traitements ciblés
Fonction cellulaire
Thérapies combinées
Efficacité du traitement
Complications
5
Cancers
Maladies neurodégénératives
Maladies auto-immunes
Réponses immunes
Troubles métaboliques
Déséquilibres
Facteurs de risque
5
Facteurs de risque
Génétique
Vieillissement
Stabilité protéique
Infections virales
Perturbations
Mode de vie
Alimentation déséquilibrée
Facteurs environnementaux
Toxines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Motifs et domaines d'intéraction protéique : Questions médicales les plus fréquentes",
"headline": "Motifs et domaines d'intéraction protéique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Motifs et domaines d'intéraction protéique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Motifs et domaines d'intéraction protéique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Éléments structuraux des protéines",
"url": "https://questionsmedicales.fr/mesh/D000072416",
"about": {
"@type": "MedicalCondition",
"name": "Éléments structuraux des protéines",
"code": {
"@type": "MedicalCode",
"code": "D000072416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Domaine B30.2-SPRY",
"alternateName": "B30.2-SPRY Domain",
"url": "https://questionsmedicales.fr/mesh/D000071197",
"about": {
"@type": "MedicalCondition",
"name": "Domaine B30.2-SPRY",
"code": {
"@type": "MedicalCode",
"code": "D000071197",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.290"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine BTB-POZ",
"alternateName": "BTB-POZ Domain",
"url": "https://questionsmedicales.fr/mesh/D000071757",
"about": {
"@type": "MedicalCondition",
"name": "Domaine BTB-POZ",
"code": {
"@type": "MedicalCode",
"code": "D000071757",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.343"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Superfamille des domaines de mort",
"alternateName": "Death Domain Superfamily",
"url": "https://questionsmedicales.fr/mesh/D000071458",
"about": {
"@type": "MedicalCondition",
"name": "Superfamille des domaines de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Domaine d'activation et de recrutement des caspases",
"alternateName": "Caspase Activation and Recruitment Domain",
"url": "https://questionsmedicales.fr/mesh/D000071476",
"about": {
"@type": "MedicalCondition",
"name": "Domaine d'activation et de recrutement des caspases",
"code": {
"@type": "MedicalCode",
"code": "D000071476",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine de mort",
"alternateName": "Death Domain",
"url": "https://questionsmedicales.fr/mesh/D000071459",
"about": {
"@type": "MedicalCondition",
"name": "Domaine de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071459",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine effecteur de mort",
"alternateName": "Death Effector Domain",
"url": "https://questionsmedicales.fr/mesh/D000071461",
"about": {
"@type": "MedicalCondition",
"name": "Domaine effecteur de mort",
"code": {
"@type": "MedicalCode",
"code": "D000071461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine pyrine",
"alternateName": "Pyrin Domain",
"url": "https://questionsmedicales.fr/mesh/D000071196",
"about": {
"@type": "MedicalCondition",
"name": "Domaine pyrine",
"code": {
"@type": "MedicalCode",
"code": "D000071196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.395.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Domaines FERM",
"alternateName": "FERM Domains",
"url": "https://questionsmedicales.fr/mesh/D000075926",
"about": {
"@type": "MedicalCondition",
"name": "Domaines FERM",
"code": {
"@type": "MedicalCode",
"code": "D000075926",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.422"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines MYND",
"alternateName": "MYND Domains",
"url": "https://questionsmedicales.fr/mesh/D000074608",
"about": {
"@type": "MedicalCondition",
"name": "Domaines MYND",
"code": {
"@type": "MedicalCode",
"code": "D000074608",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.474"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines PDZ",
"alternateName": "PDZ Domains",
"url": "https://questionsmedicales.fr/mesh/D054731",
"about": {
"@type": "MedicalCondition",
"name": "Domaines PDZ",
"code": {
"@type": "MedicalCode",
"code": "D054731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines à doigts de zinc de type RING",
"alternateName": "RING Finger Domains",
"url": "https://questionsmedicales.fr/mesh/D054829",
"about": {
"@type": "MedicalCondition",
"name": "Domaines à doigts de zinc de type RING",
"code": {
"@type": "MedicalCode",
"code": "D054829",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine d'homologie SRC",
"alternateName": "src Homology Domains",
"url": "https://questionsmedicales.fr/mesh/D018909",
"about": {
"@type": "MedicalCondition",
"name": "Domaine d'homologie SRC",
"code": {
"@type": "MedicalCode",
"code": "D018909",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Motif stérile alpha",
"alternateName": "Sterile Alpha Motif",
"url": "https://questionsmedicales.fr/mesh/D000071682",
"about": {
"@type": "MedicalCondition",
"name": "Motif stérile alpha",
"code": {
"@type": "MedicalCode",
"code": "D000071682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.813"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaine Tudor",
"alternateName": "Tudor Domain",
"url": "https://questionsmedicales.fr/mesh/D000071856",
"about": {
"@type": "MedicalCondition",
"name": "Domaine Tudor",
"code": {
"@type": "MedicalCode",
"code": "D000071856",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Domaines WW",
"alternateName": "WW Domains",
"url": "https://questionsmedicales.fr/mesh/D000074585",
"about": {
"@type": "MedicalCondition",
"name": "Domaines WW",
"code": {
"@type": "MedicalCode",
"code": "D000074585",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G02.111.570.820.709.275.750.500.937"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Motifs et domaines d'intéraction protéique",
"alternateName": "Protein Interaction Domains and Motifs",
"code": {
"@type": "MedicalCode",
"code": "D054730",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ylva Ivarsson",
"url": "https://questionsmedicales.fr/author/Ylva%20Ivarsson",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry-BMC, Uppsala University, Box 576, SE-751 23 Uppsala, Sweden. Electronic address: Yiva.ivarson@kemi.uu.se."
}
},
{
"@type": "Person",
"name": "Sobia Idrees",
"url": "https://questionsmedicales.fr/author/Sobia%20Idrees",
"affiliation": {
"@type": "Organization",
"name": "School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Keshav Raj Paudel",
"url": "https://questionsmedicales.fr/author/Keshav%20Raj%20Paudel",
"affiliation": {
"@type": "Organization",
"name": "Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Per Jemth",
"url": "https://questionsmedicales.fr/author/Per%20Jemth",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Biochemistry and Microbiology, Uppsala University, BMC Box 582, SE-75123 Uppsala, Sweden. Electronic address: Per.Jemth@imbim.uu.se."
}
},
{
"@type": "Person",
"name": "Norman E Davey",
"url": "https://questionsmedicales.fr/author/Norman%20E%20Davey",
"affiliation": {
"@type": "Organization",
"name": "Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Impact of Structured and Standardized Documentation on Documentation Quality; a Multicenter, Retrospective Study.",
"datePublished": "2022-05-27",
"url": "https://questionsmedicales.fr/article/35618978",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10916-022-01837-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Opioid Industry Documents Archive: Advancing Public Health Through Industry Document Disclosure.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38818587",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/jme.2024.62"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Documentation of prehospital emergency care].",
"datePublished": "2023-10-20",
"url": "https://questionsmedicales.fr/article/37860864",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Documentation of Phytotoxic Compounds Existing in",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/36006222",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/toxins14080561"
}
},
{
"@type": "ScholarlyArticle",
"name": "Orthopaedic surgical documentation: pre-templated operation notes significantly improve documentation of surgical procedures.",
"datePublished": "2023-01-17",
"url": "https://questionsmedicales.fr/article/36647146",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13018-022-03484-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes chimiques",
"item": "https://questionsmedicales.fr/mesh/D055598"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes biochimiques",
"item": "https://questionsmedicales.fr/mesh/D001669"
},
{
"@type": "ListItem",
"position": 4,
"name": "Conformation moléculaire",
"item": "https://questionsmedicales.fr/mesh/D008968"
},
{
"@type": "ListItem",
"position": 5,
"name": "Conformation des protéines",
"item": "https://questionsmedicales.fr/mesh/D011487"
},
{
"@type": "ListItem",
"position": 6,
"name": "Éléments structuraux des protéines",
"item": "https://questionsmedicales.fr/mesh/D000072416"
},
{
"@type": "ListItem",
"position": 7,
"name": "Motifs et domaines d'intéraction protéique",
"item": "https://questionsmedicales.fr/mesh/D054730"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Motifs et domaines d'intéraction protéique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Motifs et domaines d'intéraction protéique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Motifs et domaines d'intéraction protéique",
"description": "Comment identifier un domaine d'interaction protéique ?\nQuels tests sont utilisés pour analyser les interactions protéiques ?\nLes motifs d'interaction peuvent-ils être prédits ?\nQuels marqueurs indiquent une interaction protéique ?\nComment les mutations affectent-elles les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Documentation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Motifs et domaines d'intéraction protéique",
"description": "Quels symptômes indiquent une dysfonction protéique ?\nLes interactions protéiques peuvent-elles causer des maladies ?\nComment les maladies génétiques affectent-elles les interactions ?\nQuels signes cliniques sont liés aux troubles d'interaction ?\nLes infections peuvent-elles perturber les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Documentation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Motifs et domaines d'intéraction protéique",
"description": "Comment prévenir les maladies liées aux interactions protéiques ?\nLes dépistages sont-ils utiles pour les troubles protéiques ?\nL'éducation sur les interactions protéiques est-elle importante ?\nLes vaccins influencent-ils les interactions protéiques ?\nComment le stress affecte-t-il les interactions protéiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Documentation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Motifs et domaines d'intéraction protéique",
"description": "Quels traitements ciblent les interactions protéiques ?\nComment la thérapie génique influence-t-elle les interactions ?\nLes inhibiteurs de protéines sont-ils efficaces ?\nComment les traitements ciblent-ils les motifs d'interaction ?\nLes thérapies combinées sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Documentation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Motifs et domaines d'intéraction protéique",
"description": "Quelles complications peuvent survenir avec des interactions anormales ?\nLes complications sont-elles réversibles ?\nComment les interactions affectent-elles le vieillissement ?\nLes maladies auto-immunes sont-elles liées aux interactions ?\nLes troubles métaboliques sont-ils causés par des interactions ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Documentation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Motifs et domaines d'intéraction protéique",
"description": "Quels facteurs augmentent le risque de troubles protéiques ?\nLe vieillissement est-il un facteur de risque ?\nLes infections virales influencent-elles les interactions ?\nLe mode de vie peut-il affecter les interactions protéiques ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D054730?mesh_terms=Documentation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un domaine d'interaction protéique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par des méthodes bioinformatiques et des expériences de biologie moléculaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser les interactions protéiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le co-immunoprécipitation et les essais de double hybride."
}
},
{
"@type": "Question",
"name": "Les motifs d'interaction peuvent-ils être prédits ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des outils bioinformatiques permettent de prédire les motifs d'interaction dans les protéines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs indiquent une interaction protéique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de conformation ou des complexes protéiques stables peuvent indiquer une interaction."
}
},
{
"@type": "Question",
"name": "Comment les mutations affectent-elles les interactions protéiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent altérer la structure des motifs, perturbant ainsi les interactions normales."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction protéique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme la fatigue, des troubles métaboliques ou des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les interactions protéiques peuvent-elles causer des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions anormales peuvent contribuer à des maladies comme le cancer ou Alzheimer."
}
},
{
"@type": "Question",
"name": "Comment les maladies génétiques affectent-elles les interactions ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des défauts dans les motifs d'interaction, perturbant les fonctions cellulaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont liés aux troubles d'interaction ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'inflammation, la douleur ou des anomalies neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles perturber les interactions protéiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains pathogènes modifient les interactions protéiques pour favoriser leur survie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux interactions protéiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages sont-ils utiles pour les troubles protéiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages précoces peuvent aider à identifier des risques de maladies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation sur les interactions protéiques est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre les interactions peut aider à prévenir des maladies et à promouvoir la santé."
}
},
{
"@type": "Question",
"name": "Les vaccins influencent-ils les interactions protéiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent moduler les interactions immunitaires, renforçant la réponse du corps."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il les interactions protéiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut altérer les interactions protéiques, affectant la santé globale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les interactions protéiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de protéines ou des anticorps monoclonaux sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique influence-t-elle les interactions ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut corriger des mutations, rétablissant ainsi des interactions protéiques normales."
}
},
{
"@type": "Question",
"name": "Les inhibiteurs de protéines sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent bloquer des interactions spécifiques, offrant des options thérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment les traitements ciblent-ils les motifs d'interaction ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils visent à modifier ou à bloquer des motifs spécifiques pour restaurer la fonction cellulaire."
}
},
{
"@type": "Question",
"name": "Les thérapies combinées sont-elles bénéfiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent cibler plusieurs interactions protéiques, améliorant l'efficacité du traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des interactions anormales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des cancers, des maladies neurodégénératives ou des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les interactions affectent-elles le vieillissement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interactions protéiques altérées peuvent accélérer le vieillissement cellulaire et tissulaire."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles liées aux interactions ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions anormales peuvent déclencher des réponses auto-immunes dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils causés par des interactions ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions protéiques défectueuses peuvent entraîner des déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles protéiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme la génétique, l'environnement et le mode de vie influencent le risque."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la stabilité et la fonction des interactions protéiques."
}
},
{
"@type": "Question",
"name": "Les infections virales influencent-elles les interactions ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent perturber les interactions protéiques, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter les interactions protéiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée et le manque d'exercice peuvent altérer les interactions."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des toxines ou des polluants peuvent affecter les interactions protéiques et la santé."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Chemistry-BMC, Uppsala University, Box 576, SE-751 23 Uppsala, Sweden. Electronic address: Yiva.ivarson@kemi.uu.se.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Microbiology, Uppsala University, BMC Box 582, SE-75123 Uppsala, Sweden. Electronic address: Per.Jemth@imbim.uu.se.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Dynamics of Macromolecular Assembly, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Dynamics of Macromolecular Assembly, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.
Publications dans "Motifs et domaines d'intéraction protéique" :
2 publications dans cette catégorie
Affiliations :
Structural Biology and NMR Laboratory and The Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, New Delhi, 110078, India.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Division of Biotechnology, Netaji Subhas Institute of Technology, Dwarka, New Delhi, 110078, India.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, New Delhi, 110078, India.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Computational and Structural Biology Laboratory, Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, New Delhi, 110078, India. sbhatnagar@nsut.ac.in.
Computational and Structural Biology Laboratory, Division of Biotechnology, Netaji Subhas Institute of Technology, Dwarka, New Delhi, 110078, India. sbhatnagar@nsut.ac.in.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
School of Life Sciences, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
School of Life Sciences, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Height, Australian Centre for Neutron Scattering, New South Wales 2234, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
School of Life Sciences, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
1 publication dans cette catégorie
Affiliations :
Department of Molecular Sciences, Macquarie University, New South Wales 2109, Australia.
Publications dans "Motifs et domaines d'intéraction protéique" :
The reuse of healthcare data for various purposes will become increasingly important in the future. To enable the reuse of clinical data, structured and standardized documentation is conditional. Howe...
More than twenty-five years after the first signs of potential harm, the US remains locked in the grip of an opioid epidemic, with more Americans dying from overdoses than ever before....
The scientific documentation of prehospital emergency care in Sweden is slowly expanding. The first thesis on the value of a mobile coronary care unit was defended in 1982. Since then, at least 106 th...
The utilization of the invasive weed,...
The Royal College of Surgeons of England (RCS) Good Surgical Practice guidance identifies essential criteria for surgical operation note documentation. The current quality improvement project aims to ...
A total of fourteen categories were identified from the RCS guidance as required across all the operations identified in this study. All operations for the month of October 2021 were identified and th...
Ninety-seven cases were identified, of which 74 were freehand operation notes and 23 were pre-templated fractured neck of femur operation notes. All fourteen categories were completed in 13 (57%) of t...
Use of pre-templated operation notes results in significantly improved documentation. Adoption of generic pre-templated operation notes to improve surgical documentation should be considered across al...
Nursing documentation is essential to communicate patient care delivery. This review explores available evidence on the contribution of nursing documentation toward quality care delivery during the CO...
Historically, recordkeeping has been an essential task for health professionals. Today, this mandatory task increasingly takes place as digital documentation. This study critically examines problem co...
To assess the accuracy of documentation of the symptoms and diagnosis of delirium in medical notes of inpatients with Parkinson's disease (PD)....
The DETERMINE-PD pilot study assessed PD inpatients over 4-months. Delirium prevalence was classified prospectively using a standardized assessment at a single visit on the basis of Diagnostic and Sta...
Forty-four PD patients consented to take part in the study, accounting for 53 admissions. We identified 30 cases (56.6%) of delirium during the participants' stay in hospital. Of those with delirium i...
Delirium in PD is common. Documentation of symptoms of delirium was common; however, fails to lead to a documentation of diagnosis in over half of admissions with delirium and was even less commonly c...
Operation report documentation is essential for safe patient care and team communication, yet it is often imperfect. This qualitative study aims to understand surgeons' perspectives on operation repor...
A qualitative semi-structured interview was conducted with cleft surgeons who were asked to consider operation reports and hypothetical clinical cases. Eight operation reports performed at one centre ...
An operation report's purpose-patient care, complication documentation, future surgery, and research-will influence the detail documented. All cleft palate repair operation reports had important infor...
An understanding of surgeons' perspectives on operation report documentation is richer after this study. Surgeons know that clear documentation is essential for patient care and a skill that must be t...
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, support in clinical trials by students of human medicine and related disciplines has become of even greater importance than in pre-pand...
To overcome this shortcoming and to define a common quality standard, an interdisciplinary, multiprofessional (physicians, study nurses, medical students), and binational (Germany, The Netherlands) ex...
Following a brief description of the different roles in clinical trials (e.g., sponsor, (principal) investigator, monitor) and an introduction into the principles of GCP, the documentation of adverse ...
Serving both as textbook for self-training and as (quick-) reference work for the daily routine, the Guide has specifically been designed to complement, but not to replace practical training courses f...